Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Johnson and Johnson
Merck
Baxter
Moodys

Last Updated: January 27, 2023

Potassium chloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for potassium chloride and what is the scope of freedom to operate?

Potassium chloride is the generic ingredient in forty-four branded drugs marketed by Savage Labs, Upsher Smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Anchen Pharms, Glenmark Pharms Ltd, Granules, Lannett Co Inc, Lupin Ltd, Novel Labs Inc, Padagis Us, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Amneal, Belcher, Epic Pharma Llc, Pharma Res Software, Rubicon, Kv Pharm, Abraxis Pharm, Akorn, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Pharma Serve Ny, Watson Labs, Nexus Pharms, Icu Medical Inc, Apotex, Genus Lifesciences, Pharm Assoc, Saptalis Pharms, Wes Pharma Inc, Future Pak, Abbvie, Apothecon, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Breckenridge, Copley Pharm, Guangzhou Novaken, Mylan, Schering, Sigmapharm Labs Llc, Vitruvias Therap, Yichang Humanwell, and Novartis, and is included in one hundred and twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for potassium chloride. Eighty-six suppliers are listed for this compound. There are two tentative approvals for this compound.

Drug Prices for potassium chloride

See drug prices for potassium chloride

Drug Sales Revenue Trends for potassium chloride

See drug sales revenues for potassium chloride

Generic filers with tentative approvals for POTASSIUM CHLORIDE
Applicant Application No. Strength Dosage Form
See Plans and PricingSee Plans and Pricing20MEQTablet; Oral
See Plans and PricingSee Plans and Pricing10MEQTablet, Extended Release; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for potassium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Us POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 205993-001 Nov 5, 2015 AB2 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Prinston Inc POTASSIUM CHLORIDE potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 209026-002 Jun 11, 2019 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-004 Nov 9, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-002 Nov 9, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for potassium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nesher Pharms MICRO-K potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-002 Jun 13, 1986 See Plans and Pricing See Plans and Pricing
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-001 Jun 13, 1986 See Plans and Pricing See Plans and Pricing
Nesher Pharms MICRO-K 10 potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-002 May 14, 1984 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKinsey
Boehringer Ingelheim
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.